New Study: Cord Tissue May Hold Benefits in Multiple Sclerosis

Results from a clinical trial studying the plausibility of using cord tissue for the treatment of multiple sclerosis (MS) were published today, adding further evidence of the stem cells' ability to aid recovery for the condition. In 2015, we gave you a run-down of the latest promising results using cord tissue in the treatment of multiple sclerosis. We've also given you upbeat updates from other clinical trials and provided a little background as to how cord tissue is able to reduce abnormal immune system activity like that found in MS.

This new study followed 20 people with a median age of 41 who had been afflicted with MS for an average of nearly 8 years and underwent an infusion of cord tissue stem cells to treat the condition. It found that subjects experienced an improvement in their symptoms one month after treatment, and that was sustained for one year in many cases. In addition, no subjects showed disease progression or new lesions. One participant was able to walk with a walker after being dependent on a wheelchair, and another was able to walk freely after previously requiring a walker.

MS RAND score changes over 1 year Biggest changes were in role limitations (both physical and emotional), energy and fatigue scores and overall health

In conclusion, the study found that intravenous infusions of umbilical cord stem cells over several days are not only safe but may hold benefits: "This small study group saw improvement in bladder, bowel, and sexual dysfunction, walking, upper extremity physical function, energy and fatigue, general perspective of a positive health change and improved quality of life."